Extracorporeal Membrane Oxygenation Market By Product Type (ECMO Machines [Portable Devices and Static Devices] and Software), By Application (Respiratory Applications, Cardiac Applications, and Extracorporeal Cardiopulmonary Resuscitation (ECPR)), By Modality (Veno-Arterial, Veno-Venous, and Others), By Patient Type (Neonates, Pediatric, and Adult), and By End-User (Hospitals, Clinics and Ambulatory Surgical Centers, and Others), Global Market Size, Segmental analysis, Regional Overview, Company share analysis, Leading Company Profiles And Market Forecast, 2025 – 2035

Report Coverage:

By Product Type

• ECMO Machines
  • Portable Devices
  • Static Devices
• Software

By Application

• Respiratory Applications
• Cardiac Applications
• Extracorporeal Cardiopulmonary Resuscitation (ECPR)

By Modality

• Veno-Arterial
• Veno-Venous
• Others

By Patient Type

• Neonates
• Pediatric
• Adult

By End-User

• Hospitals
• Clinics and Ambulatory Surgical Centers
• Others

By Region

North America

• U.S.
• Canada

Europe

• U.K.
• France
• Germany
• Italy
• Spain
• Rest of Europe

Asia Pacific

• China
• Japan
• India
• Australia
• South Korea
• Singapore
• Rest of Asia Pacific

Latin America

• Brazil
• Argentina
• Mexico
• Rest of Latin America

Middle East & Africa

• GCC Countries
• South Africa
• Rest of Middle East & Africa

List of Companies:

• Medtronic Plc
• Getinge AB
• LivaNova PLC
• MicroPort Scientific Corporation
• Abbott Laboratories
• Terumo Corporation
• Alung Technologies, Inc.
• EUROSETS S.r.l.
• Nipro Corporation
• Fresenius Medical Care AG & Co. KGaA
• Baxter International Inc.
• Orion Health Pty Ltd.
• Xenios AG
• Biomedica Beteiligungs- und Handels GmbH
• CytoSorbents Corporation